Werewolf Therapeutics, Inc.
HOWL • NASDAQ
Werewolf Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel J. Hicklin, with a market cap of $37.9M.
CEODaniel J. Hicklin
Next Earnings
Upcoming earnings announcement for Werewolf Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.30
Earnings History
Past 12 earnings reports for Werewolf Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$0.20Est: -$0.34 | +41.2% | -Est: $600.0K | -100.0% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.36Est: -$0.39 | +7.7% | -Est: $600.0K | -100.0% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.40Est: -$0.42 | +4.8% | -Est: $600.0K | -100.0% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.40Est: -$0.43 | +7.0% | -Est: $300.0K | -100.0% | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.46Est: -$0.28 | -64.3% | -Est: $301.6K | -100.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.38Est: -$0.41 | +7.3% | -Est: $710.0K | -100.0% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.43Est: -$0.38 | -13.2% | $1.1MEst: $840.0K | +36.1% | 10-Q |
| May 3, 2024 | Q1 2024 | -$0.39Est: -$0.35 | -11.4% | $742.0KEst: $1.8M | -59.2% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.33Est: -$0.43 | +23.3% | $1.5MEst: $1.9M | -22.6% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.23Est: -$0.39 | +41.0% | $5.9MEst: $1.6M | +270.9% | — |
| Aug 10, 2023 | Q2 2023 | -$0.14Est: -$0.42 | +66.7% | $8.1MEst: $2.5M | +228.5% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.34Est: -$0.50 | +32.0% | $4.5MEst: $5.0M | -10.7% | — |